Table 1. NIH, State, and Foundation grants received with the assistance of one or more CTN Core Facilities.
| Principal Investigator(s) Department | Agency | Title | Dates Total award $. All years |
| M. Aitken, M.D. Pediatrics | CDC | Strike out passenger injury | 02/07-01/10 749,963 |
| “ | DHHS | Development and Evaluation of Targeted ATV Safety Educational Strategies for Rural Children | 09/07-08/10 549,642 |
| “ | ACH | Pediatric Injury Prevention Center | 07/07-06/10 741,000 |
| “ | Allstate | Building consensus for safer teen driving | 08/07-07/08 49,997 |
| “ | AR Dept Tran | Mapping the way to success toolkit & guide | 12/07-11/11 472,378 |
| “ | NHTSA | Improving Teen Driving through Parental Responsibility | 09/09-08/11 600,000 |
| “ | HSO | Child Passenger Safety Education Project | 10/10-09-11 190,000 |
| “ | NIH-NICHD subcon | Safety in Seconds 2.0 (A. Gielen PI) | 04/12-03/17 286,290 |
| “ | NIH-NICHD subcon | Neurobehavioral Outcome of Head Injury in Children (H. Levin PI) | 08/12-07/13 27,500 |
| E. Al-Chaer, Ph.D. Pediatrics | NIH-NIDDK R01 | Mechanisms of chronic visceral hyperalgesia | 09/04-03/06 335,362 |
| “ | Allergan | Treatment for irritable bowel syndrome | 09/04-12/05 545,000 |
| “ | GlaxoSmith K | Irritable bowel syndrome treatment | 09/04-09-07 360,000 |
| “ | Allergan | New agents for IBS | 09/04-12/07 1,200,000 |
| “ | NIH-NIDDK R01 | Sex hormones and visceral hypersensitivity | 04/08-03/13 1,800,000 |
| “ | NIH-NIDDK R21 | Role of Microglia in Chronic Visceral Pain | 06/09-05/11 310,000 |
| “ | NIH-NIDDK subcon | Spinal Microglial Mechanisms of Visceral Hypersensitivity (C. Saab PI) | 07/10-06/12 40,000 |
| P. Beck, M.D./Ph.D. IBS student | NIH-NINDS F30 | Role of leptin in arousal | 07/09-06/13 150,000 |
| A. Charlesworth, Ph.D. Neurobiol. (left UAMS) | Amer Heart | Role of Zar family proteins in M-phase control | 07/07-06/11 400,000 |
| “ | UAMS-MREF | Genetic analysis of development | 01/07-12/07 15,000 |
| “ | UAMS-COM | Regulation of M-phase by Zar family proteins | 11/06-12/07 15,000 |
| G. Childs, Ph.D. Neurobiology | NIH-NICHD R01 | The significance of leptin signals to somatotropes and gonadotropes | 07/09-06/14 1,754,460 |
| “ | NIH-NICHD R03 | Significance of Pituitary Leptin to Gonadotropes | 04/09-03/12 145,000 |
| C. Cole, R.N., Ph.D.
Nursing (ret.) | NIH-NINR R15 | Feasibility Study: Attention Measured in Alzheimer’s & Mild Cognitive Impairment. | 07/07-06/09 142,900 |
| “ | NIH-NINR K23 | Sleep fragmentation and Attention in Alzheimer’s Disease | 07/06-06/11 283,838 |
| “ | NIH-NINR | Tailored biobehavioral interventions in AD | 07/08-06/09 15,000 |
| “ | Beverly Healthcare | Sleep research in AD | 07/08-06/09 31,481 |
| J. Dornhoffer, M.D.
ENT | Tinnitus Res Cons | Using PET-CT to Target and Validate Low-Frequency TMS as a Treatment for Tinnitus | 07/06-06/09 300,000 |
| E. Garcia-Rill, Ph.D. Neurobiology | NIH-NINDS R01 | Central modulation of rhythms | 07/07-06/12 1,250,000 |
| S. T. Griffin, Ph.D. Geriatrics | NIH-NIA P01 | Early events in Alzheimer pathogenesis | 04/09-03/14 6,066,664 |
| R. W. Hall, M.D. Pediatrics | Medicaid | Telemedicine outreach utilizing collaborative health care | 05/08-04/13 1,458,826 |
| “ | Mayday Fnd | AR Neonate electrical stimulation study | 11/08-10/10 399,929 |
| A. Hayar, Ph.D. Neurobiology | NIH-NIDCD R03 | Synchronous bursting among juxtaglomerular neurons | 05/04-04/07 150,000 |
| “ | NIH-NIDCD R01 | External tufted cells coordinate olfactory bulb activity | 07/05-06/10 1,000,000 |
| “ | NIH-NINDS subcon | Contribution of EPL interneurons to olfaction (K. Hamilton, PI) | 04/08-03/12 150,000 |
| “ | ABI | PSD95 scaffolding of vascular K+ channels in hypertension | 01/09-10/10 38,500 |
| T. Kaiser, M.D. Pediatrics (left UAMS) | NIH-NICHD R01 | Permissive hypercapnea and IVH | 04/08-03/11 2,131,535 |
| “ | NIH-NICHD R01 subcon | Gene targets for IVH
(L. Ment, PI) | 08/07-07/12 55,515 |
| C. J. Kane, Ph.D. Neurobiology | NIH-NIAAA R01 | Microglia modulate ethanol impact on CNS development | 09/09-08/14 1,250,000 |
| M. Kiaei, Ph.D. Neurobiology | NIH-NINDS R21 | Nrf2/ARE Pathway as a Therapeutic Target for Amyotrophic Lateral Sclerosis | 03/09-02/12 239,531 |
| A, MacNicol, Ph.D.
Neurobiology | NIH-NICHD R01 | Maternal gene regulation in early vertebrate development (Co-I) | 07/07-06/12 956,250 |
| “ | AR Breast Cancer Res | Musashi2 expression as a novel breast cancer biomarker and therapeutic target (PI) | 07/12-06/13 66,481 |
| M. Mennemeier, Ph.D.
Neurobiology | NIH-NINDS R01 | Neglect and Neural Mechanisms of Magnitude Estimation | 04/05-03/10 1,784,732 |
| “ | NIH-NICHD
R03 | Rehabilitating strength perception after stroke | 12/07-11/09 100,000 |
| “ | UAMS | Arousal-related deficits in AD | 07/06-06/07 15,000 |
| “ | NIH-NCMRR R03 | Innovative treatments in spatial neglect | 04/05-03/06 142,000 |
| “ | NIH-NICHD R21 | Identifying and treating arousal related deficits in neglect and dysphagia | 01/09-12/11 350,000 |
| “ | UAMS TRI | Effect of rTMS on resting state activity in tinnitus | 10/11-09/12 49,986 |
| “ | NIH-NIDCD R21 | Maintenace rTMS for chronic tinnitus relief | 04/12-03/14 401,719 |
| S. Mulkey, M.D. Pediatrics | Thrasher Fnd (Site PI) | Neonatal Erythropoietin And Therapeutic Hypothermia Shortterm Outcome (Y. Wu PI) | 10/13-09/16 449,579 |
| N. B. Reese, PT, Ph.D. Phys Ther (UCA) | NIH-NINDS R15 | Novel Treatment for Hyperreflexia following SCI | 12/08-11/10 198,517 |
| C. Sheffer, Ph.D. Coll Pub Health (left UAMS) | Pfizer | Provider education program for treating tobacco use and dependence | 01/10-12/12 400,000 |
| “ | NIH-NCI R03 | Treatment Modality and Socioeconomic Status in Treating Tobacco Dependence | 03/10-02/12 100,000 |
| “ | NIH-NIMHD R01 | RITCh: Reducing socioeconomic disparities in tobacco dependence treatment outcomes | 07/12-06/17 966,740 |
| F. J. Urbano, Ph.D. Vis Sci (UBA) | Guggenheim | Role of calcium channels in cocaine- and methylphenidate-induced alterations | 07/11-06/12 25,000 |
| J. Watts, M.D./Ph.D. IBS student | NIH-NIDDK F30 | Novel Mechanisms of Visceral Pain: Functional Properties of Microglia | 07/10-06/13 160,000 |
| M. Watts, M.D./Ph.D. IBS student | NIH-NIDDK F30 | Alpha2-adrenoceptors modulate TRPV4 and reduce inflammation-induced visceral pain | 07/10-06/13 160,000 |